Search details
1.
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
Cell
; 172(4): 857-868.e15, 2018 02 08.
Article
in English
| MEDLINE | ID: mdl-29336889
2.
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.
Nature
; 629(8013): 919-926, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38589574
3.
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.
Blood
; 139(5): 717-731, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-34657149
4.
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
Gastric Cancer
; 27(3): 473-483, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38261067
5.
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.
Mol Cancer
; 22(1): 86, 2023 05 20.
Article
in English
| MEDLINE | ID: mdl-37210549
6.
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Gastroenterology
; 162(4): 1242-1255.e11, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34922945
7.
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
Curr Oncol Rep
; 25(9): 1017-1029, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37378881
8.
A Braf kinase-inactive mutant induces lung adenocarcinoma.
Nature
; 548(7666): 239-243, 2017 08 10.
Article
in English
| MEDLINE | ID: mdl-28783725
9.
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.
Nature
; 542(7642): 489-493, 2017 02 23.
Article
in English
| MEDLINE | ID: mdl-28199309
10.
Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice.
Genes Dev
; 29(7): 690-5, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25838540
11.
Correction: The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase.
J Cell Sci
; 136(20)2023 Oct 15.
Article
in English
| MEDLINE | ID: mdl-37855734
12.
Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.
Mol Cancer
; 22(1): 97, 2023 Jun 16.
Article
in English
| MEDLINE | ID: mdl-37328838
13.
Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.
Blood
; 127(10): 1297-306, 2016 Mar 10.
Article
in English
| MEDLINE | ID: mdl-26747246
14.
Novel RAF-directed approaches to overcome current clinical limits and block the RAS/RAF node.
Mol Oncol
; 2024 Feb 16.
Article
in English
| MEDLINE | ID: mdl-38362705
15.
Exploiting signaling rewiring in cancer cells with co-existing oncogenic drivers.
Mol Oncol
; 17(11): 2215-2217, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37872865
16.
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.
Cancer Cell
; 41(12): 2100-2116.e10, 2023 12 11.
Article
in English
| MEDLINE | ID: mdl-38039964
17.
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Sci Transl Med
; 15(702): eabo3826, 2023 06 28.
Article
in English
| MEDLINE | ID: mdl-37379367
18.
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Nat Cancer
; 4(7): 1016-1035, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37430060
19.
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma.
Mol Ther
; 19(12): 2201-12, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21829174
20.
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer.
Drugs Context
; 112022.
Article
in English
| MEDLINE | ID: mdl-36452878